🇺🇸 FDA
Pipeline program

Vonafexor, ROSUVASTATIN , IOHEXOL , Vonafexor

EYP001-210

Phase 2 small_molecule active

Quick answer

Vonafexor, ROSUVASTATIN , IOHEXOL , Vonafexor for Impaired renal function and suspected MASH is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Impaired renal function and suspected MASH
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials